Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

VIDALISTA-2.5

Description: Vidalista-2.5 is a pharmaceutical product manufactured by Centurion Laboratories. It contains Tadalafil as its active substance and is primarily utilized to treat erectile dysfunction (ED) and symptoms of benign prostatic hyperplasia (BPH) in men. Vidalista-2.5 is available in tablet form, with each tablet containing 2.5 mg of Tadalafil.

Active Substance: Tadalafil is the active substance in Vidalista-2.5, belonging to the class of phosphodiesterase type 5 (PDE5) inhibitors. It acts by increasing blood flow to the penis during sexual stimulation, facilitating erections. Additionally, Tadalafil also relaxes smooth muscles in the prostate and bladder, leading to an improvement in urinary symptoms associated with benign prostatic hyperplasia (BPH).

Manufacturer: Vidalista-2.5 is manufactured by Centurion Laboratories, a reputable pharmaceutical company known for its dedication to producing high-quality medications. Centurion Laboratories adheres to stringent manufacturing standards to ensure the safety, efficacy, and consistency of its products.

Formulation: Each package of Vidalista-2.5 typically contains 10 tablets, with each tablet containing 2.5 mg of Tadalafil. This formulation provides an adequate supply for multiple doses and allows for convenient use as needed.

Usage and Dosage: Vidalista-2.5 tablets are taken orally, usually once a day, regardless of the timing of sexual activity. The recommended starting dose for erectile dysfunction is 2.5 mg, although this may be adjusted based on individual response and tolerance. For the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction, the usual dose is 5 mg once daily. It is essential to follow the prescribing healthcare provider’s instructions carefully and not to exceed the recommended dose.

Storage Conditions: Vidalista-2.5 tablets should be stored in a cool, dry place at room temperature, away from direct sunlight and moisture. It is crucial to keep them out of reach of children and pets to prevent accidental ingestion. Proper storage helps maintain the stability and efficacy of the medication.

Mechanism of Action: Tadalafil in Vidalista-2.5 acts by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which degrades cyclic guanosine monophosphate (cGMP) in the corpus cavernosum and smooth muscles of the prostate and bladder. By inhibiting PDE5, Tadalafil prolongs the action of cGMP, promoting smooth muscle relaxation and increased blood flow to the penis, resulting in erections suitable for sexual activity. Additionally, it also improves urinary symptoms associated with benign prostatic hyperplasia (BPH).